原发性甲状旁腺功能亢进症甲状旁腺切除术后长期生活质量:系统综述
该系统综述纳入31项研究、3298例原发性甲状旁腺功能亢进症患者,评估甲状旁腺切除术后至少1年的生活质量。27项研究(87%)显示术后长期生活质量评分显著改善,其中1项显示改善持续至术后10年。建议诊断时使用经验证的生活质量工具筛查,以辅助术前讨论手术指征。
要点
- 甲状旁腺切除术后长期生活质量显著改善,87%的研究支持该结论。
- 改善可持续长达10年,但证据来自单中心研究。
- 诊断时应使用SF-36或PAS等工具筛查生活质量,辅助手术决策。
核心结论
- 甲状旁腺切除术与原发性甲状旁腺功能亢进症患者长期生活质量的改善和维持相关。
研究设计与样本
- 系统综述,检索PubMed和Scopus(1998年6月至2021年2月15日),遵循PRISMA策略。
- 纳入31项研究,来自14个国家,随访至少1年;共3298例患者(2975例手术,323例观察),5445名年龄性别匹配对照,386例良性甲状腺疾病对照。
- 生活质量评估工具:21项研究(68%)使用SF-36,8项(26%)使用PAS,其余使用10种其他工具的组合。
- 中位随访1年(范围1-10年)。
主要发现
- 31项研究中27项(87%)显示甲状旁腺切除术后长期生活质量评分显著改善。
- 1项研究显示术后10年生活质量持续改善。
- 其余4项研究(13%)报告混合结果。
临床怎么用
- 建议在诊断时使用经验证的生活质量工具(如SF-36或PAS)对原发性甲状旁腺功能亢进症患者进行筛查。
- 筛查结果可用于术前讨论非特异性神经认知症状及甲状旁腺切除术后长期生活质量改善的潜力,辅助手术指征的评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Definitive treatment of primary hyperparathyroidism (pHPT) with curative parathyroidectomy has been shown to improve nonspecific neurocognitive symptoms and may improve long-term quality of life (QOL). However, QOL is not currently routinely assessed preoperatively, and as a result, diminished QOL may be overlooked as an indication for surgery. OBJECTIVE: To examine results for measures of long-term QOL after parathyroidectomy in patients with pHPT. EVIDENCE REVIEW: A systematic, English-language literature review was performed to assess the long-term association of parathyroidectomy, defined as a minimum of 1-year postoperative follow-up, with QOL in patients with pHPT. We conducted a search of PubMed and Scopus using Medical Subject Heading (MeSH) terms for hyperparathyroidism, parathyroid hormone, parathyroidectomy, hypercalcemia, and quality of life. All relevant literature published between June 1998 and February 15, 2021, was included. Study selection was guided by the Preferred Reporting Items for Systematic Review and Meta-analyses (PRISMA) strategy. FINDINGS: Thirty-one studies conducted in 14 countries with a minimum of 1 year of follow-up were included, comprising 3298 patients with pHPT (2975 underwent parathyroidectomy; 323 were observed), 5445 age- and sex-matched control participants, and 386 control patients with benign thyroid disease. To assess QOL, 21 studies (68%) used a general tool, the 36-item Short Form Survey (SF-36), and 8 (26%) used the disease-specific tool Parathyroidectomy Assessment of Symptoms (PAS). The remaining studies used a combination of 10 additional QOL tools. The median follow-up period was 1 year (range, 1-10 years). Of the 31 studies, 27 (87%) demonstrated significant score improvement in long-term QOL after parathyroidectomy, including 1 study that showed continued improvement in QOL 10 years after parathyroidectomy. The remaining 4 studies (13%) reported mixed results. CONCLUSIONS AND RELEVANCE: This systematic review suggests that parathyroidectomy is associated with improved and sustained QOL in patients with pHPT. Patients with pHPT should be screened with a validated QOL tool such as the SF-36 or PAS at the time of diagnosis to guide discussion of these symptoms in the preoperative setting and the potential for long-term improvement after curative parathyroidectomy.
引用
- Livschitz J, Yen TWF, Evans DB, et al. Long-term Quality of Life After Parathyroidectomy for Primary Hyperparathyroidism: A Systematic Review. JAMA Surg. 2022. PMID: 36103163. doi:10.1001/jamasurg.2022.4249
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。